Sonnet Biotherapeutc Hldng I
13F holders, Q1 2024 (March 31)10holders
$1.86avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Sonnet Biotherapeutc Hldng I in their 13F filings. The largest holders were Susquehanna International Group, LLP ($64K), Vanguard Group Inc. ($27K) and Virtu Financial LLC ($20K).
- Company
- Sonnet Biotherapeutc Hldng I
- CUSIP
- 83548R303
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $84K |
| Exits | 4 | $127K |
Ownership 10 holders
| Susquehanna International Group, LLP | 0.00% | New | 34,453 | $64K |
| Vanguard Group Inc. | 0.00% | No change | 14,726 | $27K |
| Virtu Financial LLC | 0.00% | New | 10,843 | $20K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +30.0% | 2,723 | $5K |
| BlackRock Inc. | 0.00% | Reduce -12.5% | 520 | $967 |
| Citigroup Inc. | 0.00% | New | 38 | $71 |
| Wells Fargo & Company | 0.00% | Add +4.8% | 22 | $41 |
| Bank of America Corp. | 0.00% | New | 6 | $11 |
| Morgan Stanley | 0.00% | Reduce -90.2% | 6 | $11 |
| Private Wealth Management Group, LLC | 0.00% | No change | 3 | $6 |
"% of holder's portfolio" is SONNET BIOTHERAPEUTC HLDNG I's weight in each manager's 13F, not the share of Sonnet Biotherapeutc Hldng I the manager owns.